Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
POSTED
07-27-21
Prioritizing the Needs of the Black LGBTQ+ Community in an Innovative HIV Trial
POSTED
06-22-21
Adonis Timone Aims to Create Change With Advocates for Youth
POSTED
06-15-21
It's Time to Pass the Equality Act
POSTED
06-03-21
Lance Toma Creates Safe Spaces for San Francisco's LGBTQ+ AAPI Community
POSTED
05-27-21
Four Questions With Wayne Duffus: Addressing Health Disparities in HIV Prevention and Care
POSTED
05-19-21
A Workplace for Tomorrow
POSTED
04-24-20
Committed to Reducing Greenhouse Gas Emissions for a Healthier World
Gilead views environmental stewardship as critical to help the company achieve its mission and last year announced a goal to reduce gr...
POSTED
04-14-20
Ramping Up Manufacturing to Help Address COVID-19
As the number of confirmed COVID-19 cases increased in Asia and began to spread to other regions around the world, a team of employees at Gilead’s manufacturing site in La Verne, California met in the early morning of Monday, Feb. 3.
The topic of the meeting: How quickly could the site beg...
POSTED
04-02-20
An Open Letter from our Chairman and CEO
Daniel O'Day
When the news of the coronavirus first emerged, Gilead immediately began to investigate the potential of remdesivir, a medicine we had been studying for many years as part of our extensive research in antivirals. Remdesivir had never been approved for use but based on...
POSTED
03-25-20
Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak
For those with potentially immunosuppressing conditions, such as HIV, the uncertainty caused by the novel coronavirus pandemic can be particularly challenging. Gilead remains focused on ensuring that people living with or at risk for HIV have access to the medications and ...